Publications by authors named "David Bylund"

Claim this Profile
R
Receptor Binding Assays and Drug Discovery.
David B Bylund, S J Enna

Adv Pharmacol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative versus qualitative data: the numerical dimensions of drug action.
David B Bylund, Myron L Toews

Biochem Pharmacol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Replicated, replicable and relevant-target engagement and pharmacological experimentation in the 21st century.
Terry Kenakin, David B Bylund, Myron L Toews, Kevin Mullane, Raymond J Winquist

Biochem Pharmacol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radioligand binding methods for membrane preparations and intact cells.
David B Bylund, Myron L Toews

Methods Mol Biol· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Src family kinase inhibitor improves survival in experimental acute liver failure associated with elevated cerebral and circulating vascular endothelial growth factor levels.
Richard J Aspinall, Sara M Weis, Leo Barnes, Kimberly Lutu-Fuga, David J Bylund

Liver Int· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential effects of inescapable stress on locus coeruleus GRK3, alpha2-adrenoceptor and CRF1 receptor levels in learned helpless and non-helpless rats: a potential link to stress resilience.
Manish Taneja, Samina Salim, Kaustuv Saha, H Kevin Happe, Nidal Qutna, David B Bylund

Behav Brain Res· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular modelling of subtypes (alpha(2A), alpha(2B) and alpha(2C)) of alpha(2)-adrenoceptors: a comparative study.
Balázs Balogh, András Szilágyi, Klára Gyires, David B Bylund, Péter Mátyus

Neurochem Int· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment with escitalopram but not desipramine decreases escape latency times in a learned helplessness model using juvenile rats.
Abbey L Reed, Jeffrey C Anderson, David B Bylund, Frederick Petty, Hesham El Refaey

Psychopharmacology (Berl)· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alpha-2 adrenergic-induced changes in rectal temperature in adult and 13-day old rats following acute and repeated desipramine administration.
Jean D Deupree, William J Burke, David B Bylund

BMC Pharmacol· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
Juvenile rats in the forced-swim test model the human response to antidepressant treatment for pediatric depression.
Abbey L Reed, H Kevin Happe, Frederick Petty, David B Bylund

Psychopharmacology (Berl)· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The differential regulation of BDNF and TrkB levels in juvenile rats after four days of escitalopram and desipramine treatment.
Megan E Kozisek, David Middlemas, David B Bylund

Neuropharmacology· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brain-derived neurotrophic factor and its receptor tropomyosin-related kinase B in the mechanism of action of antidepressant therapies.
Megan E Kozisek, David Middlemas, David B Bylund

Pharmacol Ther· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological properties of the active metabolites of the antidepressants desipramine and citalopram.
Jean D Deupree, Megan D Montgomery, David B Bylund

Eur J Pharmacol· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alpha- and beta-adrenergic receptors: Ahlquist's landmark hypothesis of a single mediator with two receptors.
David B Bylund

Am J Physiol Endocrinol Metab· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selecting selectivities and the neuropharmacology of antidepressant drug action: a commentary.
David B Bylund

FASEB J· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Childhood and adolescent depression: why do children and adults respond differently to antidepressant drugs?
David B Bylund, Abbey L Reed

Neurochem Int· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Today's research, tomorrow's health: focus on pharmacogenomics.
David B Bylund, Megan E Kozisek, Megan D Montgomery, Abbey L Reed

Per Med· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Appropriate dosing regimens for treating juvenile rats with desipramine for neuropharmacological and behavioral studies.
Megan E Kozisek, Jean D Deupree, William J Burke, David B Bylund

J Neurosci Methods· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential effects of the tricyclic antidepressant desipramine on the density of adrenergic receptors in juvenile and adult rats.
Jean D Deupree, Abbey L Reed, David B Bylund

J Pharmacol Exp Ther· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the maturation of the adrenergic and serotonergic neurotransmitter systems in the brain: implications for differential drug effects on juveniles and adults.
L Charles Murrin, Jeff D Sanders, David B Bylund

Biochem Pharmacol· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of brain adrenergic receptors in dopamine-beta-hydroxylase knockout mice.
Jeff D Sanders, Patricia Szot, David Weinshenker, H Kevin Happe, David B Bylund

Brain Res· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacologic principles for combination therapy.
Myron L Toews, David B Bylund

Proc Am Thorac Soc· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NIGMS-sponsored integrative and organ systems pharmacology: synopsis of the 2005 experience/anticipation of the 2006 short courses.
David B Bylund, Laurence L Brunton, Peter J R Cobbett, Adam M Persky, Peter C Preusch

Mol Interv· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the active site of phenylethanolamine N-methyltransferase with 3-hydroxyethyl- and 3-hydroxypropyl-7-substituted-1,2,3,4-tetrahydroisoquinolines.
Gary L Grunewald, F Anthony Romero, Mitchell R Seim, Kevin R Criscione, Jean D Deupree, David B Bylund

Bioorg Med Chem Lett· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alpha-2 adrenoceptor subtypes: are more better?
David B Bylund

Br J Pharmacol· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis